1. Home
  2. NOTV vs MTNB Comparison

NOTV vs MTNB Comparison

Compare NOTV & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • MTNB
  • Stock Information
  • Founded
  • NOTV 1974
  • MTNB 2013
  • Country
  • NOTV United States
  • MTNB United States
  • Employees
  • NOTV N/A
  • MTNB N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • MTNB Biotechnology: Pharmaceutical Preparations
  • Sector
  • NOTV Health Care
  • MTNB Health Care
  • Exchange
  • NOTV Nasdaq
  • MTNB Nasdaq
  • Market Cap
  • NOTV 40.4M
  • MTNB 35.1M
  • IPO Year
  • NOTV 1997
  • MTNB N/A
  • Fundamental
  • Price
  • NOTV $1.67
  • MTNB $3.59
  • Analyst Decision
  • NOTV Buy
  • MTNB Strong Buy
  • Analyst Count
  • NOTV 3
  • MTNB 1
  • Target Price
  • NOTV $5.25
  • MTNB $150.00
  • AVG Volume (30 Days)
  • NOTV 183.0K
  • MTNB 60.5K
  • Earning Date
  • NOTV 08-08-2024
  • MTNB 11-06-2024
  • Dividend Yield
  • NOTV N/A
  • MTNB N/A
  • EPS Growth
  • NOTV N/A
  • MTNB N/A
  • EPS
  • NOTV N/A
  • MTNB N/A
  • Revenue
  • NOTV $501,062,000.00
  • MTNB N/A
  • Revenue This Year
  • NOTV N/A
  • MTNB N/A
  • Revenue Next Year
  • NOTV $8.69
  • MTNB N/A
  • P/E Ratio
  • NOTV N/A
  • MTNB N/A
  • Revenue Growth
  • NOTV N/A
  • MTNB N/A
  • 52 Week Low
  • NOTV $1.23
  • MTNB $3.28
  • 52 Week High
  • NOTV $11.42
  • MTNB $44.50
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 54.83
  • MTNB 22.53
  • Support Level
  • NOTV $1.23
  • MTNB $3.40
  • Resistance Level
  • NOTV $1.63
  • MTNB $4.16
  • Average True Range (ATR)
  • NOTV 0.16
  • MTNB 0.32
  • MACD
  • NOTV 0.05
  • MTNB 0.07
  • Stochastic Oscillator
  • NOTV 62.86
  • MTNB 22.77

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.

About MTNB Matinas Biopharma Holdings Inc.

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Share on Social Networks: